NYSE:BHC - Bausch Health Companies Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $15.67
  • Forecasted Upside: 83.67 %
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
▲ +0.17 (2.03%)

This chart shows the closing price for BHC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Bausch Health Companies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BHC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BHC

Analyst Price Target is $15.67
▲ +83.67% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Bausch Health Companies in the last 3 months. The average price target is $15.67, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 83.67% upside from the last price of $8.53.

This chart shows the closing price for BHC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 6 polled investment analysts is to buy stock in Bausch Health Companies. This rating has held steady since January 2022, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 8 buy ratings
  • 4 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 7 buy ratings
  • 4 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/13/2022JPMorgan Chase & Co.Initiated CoverageOverweight$12.00High
5/26/2022Piper SandlerLower Price Target$27.00 ➝ $7.00Low
5/15/2022Royal Bank of CanadaLower Price TargetOutperform$21.00 ➝ $17.00Low
5/11/2022BMO Capital MarketsLower Price Target$26.00 ➝ $15.00High
5/11/2022Bank of AmericaLower Price Target$25.00 ➝ $12.00High
5/9/2022Royal Bank of CanadaLower Price TargetOutperform$32.00 ➝ $21.00High
2/1/2022Royal Bank of CanadaLower Price TargetOutperform$40.00 ➝ $34.00Low
11/8/2021BMO Capital MarketsReiterated RatingHoldLow
11/3/2021Royal Bank of CanadaLower Price TargetOutperform$41.00 ➝ $40.00High
10/1/2021Jefferies Financial GroupReiterated RatingBuyHigh
8/4/2021BarclaysLower Price TargetIn-Line ➝ Overweight$35.00 ➝ $31.00High
7/8/2021HC WainwrightReiterated RatingBuyLow
5/5/2021Royal Bank of CanadaLower Price TargetOutperform$42.00 ➝ $41.00Low
3/30/2021Bank of AmericaReiterated RatingNeutral ➝ Underperform$27.00Low
3/24/2021Bank of AmericaDowngradeNeutral ➝ Underperform$27.00Low
3/16/2021HC WainwrightBoost Price TargetBuy$50.00 ➝ $55.00Low
3/14/2021JPMorgan Chase & Co.Reiterated RatingBuy$38.00Low
3/2/2021CitigroupBoost Price Target$32.00 ➝ $37.00Low
2/26/2021Morgan StanleyBoost Price TargetEqual Weight$22.00 ➝ $35.00Medium
2/25/2021BarclaysBoost Price TargetOverweight$27.00 ➝ $35.00Low
2/17/2021Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$26.00 ➝ $42.00Low
2/16/2021JPMorgan Chase & Co.Boost Price TargetOverweight$32.00 ➝ $38.00Low
1/22/2021Piper SandlerDowngradeOverweight ➝ Neutral$25.00 ➝ $30.00Low
1/15/2021Jefferies Financial GroupBoost Price Target$27.00 ➝ $33.00Low
11/5/2020Piper SandlerLower Price TargetOverweight$26.00 ➝ $25.00Low
10/28/2020Wells Fargo & CompanyLower Price TargetEqual Weight$18.00 ➝ $17.00Medium
10/26/2020BarclaysBoost Price TargetOverweight$28.00 ➝ $29.00High
9/17/2020Bank of AmericaUpgradeUnderperform ➝ Neutral$19.00High
8/24/2020HC WainwrightReiterated RatingBuy$64.00 ➝ $50.00High
8/19/2020Piper SandlerLower Price TargetOverweight$32.00 ➝ $26.00High
8/10/2020Royal Bank of CanadaBoost Price TargetSector Perform$23.00 ➝ $26.00Low
8/10/2020CitigroupLower Price TargetBuy$27.00 ➝ $26.00Medium
8/7/2020BarclaysBoost Price TargetOverweight$25.00 ➝ $28.00High
7/31/2020Royal Bank of CanadaLower Price TargetSector Perform$24.00 ➝ $23.00Low
7/7/2020Bank of AmericaBoost Price TargetUnderperform$12.00 ➝ $14.00High
6/17/2020HC WainwrightBoost Price TargetBuy$50.00 ➝ $64.00Medium
5/8/2020CfraLower Price TargetHold$28.00 ➝ $18.00Low
5/8/2020SunTrust BanksLower Price TargetBuy$25.00 ➝ $24.00High
5/8/2020Royal Bank of CanadaLower Price TargetSector Perform$25.00 ➝ $24.00High
4/30/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$17.00 ➝ $18.00Low
4/28/2020HC WainwrightReiterated RatingBuy$50.00Medium
4/28/2020Royal Bank of CanadaLower Price TargetSector Perform$26.00 ➝ $25.00High
4/24/2020CitigroupInitiated CoverageBuy$30.00High
4/23/2020Jefferies Financial GroupLower Price TargetBuy$35.00 ➝ $27.00Medium
4/2/2020Morgan StanleyDowngradeOverweight ➝ Equal WeightLow
3/23/2020HC WainwrightLower Price TargetBuy$60.00 ➝ $50.00High
3/23/2020Wells Fargo & CompanyLower Price TargetEqual Weight$32.00 ➝ $17.00High
3/17/2020Royal Bank of CanadaLower Price TargetSector Perform$31.00 ➝ $26.00Medium
2/20/2020Royal Bank of CanadaLower Price TargetSector Perform$33.00 ➝ $31.00High
2/20/2020SunTrust BanksLower Price TargetBuy$32.00 ➝ $31.00Low
2/19/2020CowenReiterated RatingBuy$40.00Low
2/19/2020GuggenheimReiterated RatingBuy$36.00Low
2/11/2020Morgan StanleyLower Price TargetOverweight$34.00 ➝ $32.00Low
2/4/2020Royal Bank of CanadaBoost Price TargetSector Perform$31.00 ➝ $33.00High
1/29/2020Wolfe ResearchDowngradeOutperform ➝ Peer PerformLow
1/26/2020BarclaysReiterated RatingBuy$33.00Low
1/22/2020Wells Fargo & CompanyUpgradeUnderweight ➝ Equal Weight$32.00Medium
12/30/2019Piper Jaffray CompaniesBoost Price TargetNeutral ➝ Overweight$30.00 ➝ $39.00Medium
12/23/2019HC WainwrightReiterated RatingBuy$60.00N/A
12/12/2019JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$32.00 ➝ $38.00High
12/2/2019HC WainwrightReiterated RatingBuy$54.00 ➝ $60.00Low
12/2/2019The Goldman Sachs GroupInitiated CoverageNeutral$30.00Low
11/5/2019BarclaysBoost Price TargetOverweight$28.00 ➝ $30.00Low
10/25/2019CowenInitiated CoverageOutperform$35.00Medium
9/17/2019Wells Fargo & CompanyReiterated RatingSellLow
9/12/2019GuggenheimInitiated CoverageBuy$30.00High
8/15/2019TD SecuritiesUpgradeHold ➝ Buy$28.00Medium
8/7/2019HC WainwrightBoost Price TargetMarket Perform ➝ Buy$50.00 ➝ $54.00Low
7/29/2019HC WainwrightLower Price TargetBuy$58.00 ➝ $50.00Low
7/19/2019Wolfe ResearchInitiated CoverageOutperform ➝ Outperform$31.00Low
7/15/2019Wells Fargo & CompanyReiterated RatingSellLow
7/8/2019BarclaysSet Price TargetBuy$28.00Low
6/20/2019MizuhoSet Price TargetBuy$45.00Medium
6/11/2019Piper Jaffray CompaniesSet Price TargetBuy$29.00Medium
6/11/2019BarclaysReiterated RatingOverweight ➝ Overweight$28.00Medium
5/31/2019Cantor FitzgeraldSet Price TargetBuy$32.00Low
5/17/2019Wells Fargo & CompanySet Price TargetSell$9.00Low
5/13/2019JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$24.80Low
5/7/2019MizuhoBoost Price TargetBuy$41.00 ➝ $45.00Low
4/25/2019Cantor FitzgeraldReiterated RatingBuy$32.00Low
4/2/2019Piper Jaffray CompaniesSet Price TargetBuy$28.00Low
3/20/2019Bank of AmericaReiterated RatingUnderperform$18.00High
3/19/2019SunTrust BanksInitiated CoverageBuy ➝ Buy$30.00High
3/18/2019MizuhoBoost Price TargetBuy$39.00 ➝ $41.00High
2/28/2019HC WainwrightReiterated RatingBuyMedium
2/19/2019Wells Fargo & CompanyBoost Price TargetSell ➝ Underperform$9.00 ➝ $25.19High
1/6/2019MizuhoReiterated RatingBuy$39.00High
1/2/2019UBS GroupUpgradeBuyHigh
1/1/2019Piper Jaffray CompaniesUpgradeNeutral ➝ Overweight$27.00High
12/17/2018Morgan StanleySet Price TargetBuy$32.00High
12/14/2018HC WainwrightUpgradeAverage ➝ BuyLow
12/12/2018Wells Fargo & CompanySet Price TargetSell$9.00Medium
11/30/2018MizuhoBoost Price TargetBuy ➝ Buy$35.00 ➝ $38.00Low
11/13/2018BMO Capital MarketsReiterated RatingHold$26.00Medium
11/7/2018TD SecuritiesBoost Price TargetHold$24.00 ➝ $28.00Low
11/7/2018Royal Bank of CanadaBoost Price TargetHold$30.00 ➝ $31.00Medium
11/6/2018Cantor FitzgeraldReiterated RatingBuyN/A
11/5/2018Morgan StanleyUpgradeEqual Weight ➝ Overweight$32.00High
10/15/2018HC WainwrightSet Price TargetHold$25.00Low
10/8/2018HC WainwrightSet Price TargetHold$25.00Medium
10/8/2018MizuhoReiterated RatingBuy$35.00Medium
10/8/2018Royal Bank of CanadaSet Price TargetSector Perform ➝ Hold$26.00 ➝ $30.00Medium
9/13/2018HC WainwrightReiterated RatingHold$25.00High
9/13/2018Piper Jaffray CompaniesUpgradeUnderweight ➝ Neutral$16.00 ➝ $19.00High
9/12/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy$30.00High
9/12/2018Cantor FitzgeraldReiterated RatingBuy$32.00High
8/31/2018HC WainwrightReiterated RatingHold$20.00Medium
8/13/2018BMO Capital MarketsBoost Price TargetMarket Perform ➝ Market Perform$20.00 ➝ $22.00Medium
8/8/2018Royal Bank of CanadaBoost Price TargetHold$25.00 ➝ $26.00Low
8/8/2018JPMorgan Chase & Co.Boost Price TargetUnderweight$18.00Low
8/7/2018Piper Jaffray CompaniesSet Price TargetSell$16.00Low
8/7/2018Cantor FitzgeraldReiterated RatingBuy$32.00Low
8/7/2018MizuhoReiterated RatingBuy$31.00High
8/6/2018Wells Fargo & CompanyReiterated RatingSellHigh
7/23/2018Piper Jaffray CompaniesSet Price TargetSell$13.00Low
6/29/2018Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
6/29/2018MizuhoReiterated RatingBuy$31.00Medium
6/22/2018TD SecuritiesDowngradeBuy ➝ Hold$24.00Low
6/20/2018HC WainwrightReiterated RatingHold$20.00Low
6/6/2018BarclaysUpgradeEqual Weight ➝ Overweight$20.00 ➝ $34.00High
6/5/2018HC WainwrightSet Price TargetHold$20.00High
6/1/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy$25.00Low
5/15/2018MizuhoUpgradeNeutral ➝ BuyLow
5/14/2018Cantor FitzgeraldSet Price TargetBuy$25.00Low
5/11/2018BMO Capital MarketsBoost Price TargetMarket Perform$17.00 ➝ $20.00Low
5/9/2018BTIG ResearchReiterated RatingHoldLow
5/9/2018Jefferies Financial GroupBoost Price TargetBuy$23.00Low
5/9/2018TD SecuritiesBoost Price TargetBuy$23.00 ➝ $24.00Low
5/9/2018Royal Bank of CanadaBoost Price TargetSector Perform$18.00 ➝ $19.00Low
5/9/2018JPMorgan Chase & Co.Set Price TargetSell$13.00High
5/9/2018Piper Jaffray CompaniesSet Price TargetSell$13.00Low
5/8/2018The Goldman Sachs GroupSet Price TargetSell$16.00Medium
5/8/2018Cantor FitzgeraldSet Price TargetBuy$25.00High
5/7/2018HC WainwrightReiterated RatingPositive ➝ Hold$16.00Medium
5/2/2018Royal Bank of CanadaSet Price TargetHold$18.00Medium
4/30/2018Deutsche Bank AktiengesellschaftBoost Price TargetBuy$20.00 ➝ $22.00Low
4/6/2018MizuhoUpgradeUnderperform ➝ Neutral$10.00 ➝ $15.00High
3/21/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy$20.00Medium
3/20/2018Wells Fargo & CompanyReiterated RatingSellMedium
3/15/2018HC WainwrightReiterated RatingHold$16.00Medium
3/12/2018Wells Fargo & CompanyReiterated RatingSellLow
3/5/2018Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$18.00Low
3/1/2018TD SecuritiesLower Price TargetBuy$27.00 ➝ $23.00Low
3/1/2018Piper Jaffray CompaniesReiterated RatingSell$12.00 ➝ $10.00High
2/28/2018Cantor FitzgeraldSet Price TargetBuy$25.00Medium
2/28/2018Wells Fargo & CompanyReiterated RatingSellMedium
2/26/2018HC WainwrightReiterated RatingNeutral$18.00Low
2/21/2018Deutsche Bank AktiengesellschaftSet Price TargetHold$20.00Low
1/24/2018The Goldman Sachs GroupInitiated CoverageSell ➝ Sell$18.00High
1/19/2018Cantor FitzgeraldSet Price TargetBuy$25.00Medium
1/16/2018Wells Fargo & CompanyReiterated RatingSell$9.00Low
1/16/2018HC WainwrightBoost Price TargetBuy$17.00 ➝ $24.00High
1/16/2018HC WainwrightSet Price TargetHold$17.00 ➝ $24.00High
1/5/2018TD SecuritiesBoost Price TargetBuy$20.00 ➝ $27.00High
1/4/2018Wells Fargo & CompanyReiterated RatingSellLow
1/1/2018Cantor FitzgeraldSet Price TargetBuy$25.00High
12/26/2017Cantor FitzgeraldSet Price TargetBuy$25.00Low
12/15/2017MizuhoBoost Price TargetUnderperform ➝ Underperform$7.00 ➝ $10.00Medium
12/14/2017JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$12.00High
12/3/2017Deutsche Bank AktiengesellschaftSet Price TargetHold$18.00Low
11/16/2017Deutsche Bank AktiengesellschaftSet Price TargetHold$19.00 ➝ $18.00N/A
11/13/2017Wells Fargo & CompanyReiterated RatingSellN/A
11/13/2017BMO Capital MarketsBoost Price TargetMarket Perform$16.00 ➝ $17.00N/A
11/10/2017Piper Jaffray CompaniesReiterated RatingSell$12.00N/A
11/9/2017HC WainwrightReiterated RatingHold$17.00N/A
11/8/2017Royal Bank of CanadaSet Price TargetSector Perform$18.00N/A
11/8/2017Deutsche Bank AktiengesellschaftReiterated RatingHold$19.00N/A
11/7/2017TD SecuritiesUpgradeHold ➝ Buy$20.00N/A
11/3/2017TD SecuritiesUpgradeHold ➝ Buy$20.00N/A
11/3/2017HC WainwrightReiterated RatingHold$17.00N/A
10/31/2017Cantor FitzgeraldSet Price TargetBuy$23.00N/A
10/30/2017BMO Capital MarketsReiterated RatingHold$16.00N/A
10/27/2017Wells Fargo & CompanyReiterated RatingSellN/A
10/22/2017Piper Jaffray CompaniesSet Price TargetSell$14.00N/A
10/20/2017Royal Bank of CanadaLower Price TargetSector Perform$21.00 ➝ $18.00N/A
10/9/2017Deutsche Bank AktiengesellschaftReiterated RatingHold$18.00N/A
10/4/2017HC WainwrightReiterated RatingHold$17.00Low
9/30/2017Wells Fargo & CompanyReiterated RatingUnderperform$8.00High
9/28/2017Cantor FitzgeraldReiterated RatingBuy$23.00Low
9/25/2017Deutsche Bank AktiengesellschaftReiterated RatingHold$19.00Low
9/18/2017HC WainwrightReiterated RatingHold$17.00Low
9/17/2017Piper Jaffray CompaniesReiterated RatingSell$14.00Low
8/29/2017Cantor FitzgeraldReiterated RatingBuy$23.00Low
8/29/2017MizuhoReiterated RatingSell$8.00 ➝ $7.00High
8/21/2017Deutsche Bank AktiengesellschaftSet Price TargetHold$19.00High
8/21/2017Stifel NicolausReiterated RatingBuy$45.00Medium
8/21/2017HC WainwrightSet Price TargetHold$17.00Low
8/16/2017Cantor FitzgeraldSet Price TargetBuy$23.00Low
8/10/2017BMO Capital MarketsReiterated RatingMarket Perform$16.00Low
8/10/2017Rodman & RenshawReiterated RatingNeutral$17.00High
8/10/2017Jefferies Financial GroupReiterated RatingBuy$18.00High
8/10/2017Stifel NicolausReiterated RatingBuy$35.00Medium
8/10/2017Wells Fargo & CompanyReiterated RatingUnderperform$9.00Medium
8/9/2017MizuhoReiterated RatingUnderperform$8.00Medium
8/9/2017ScotiabankBoost Price TargetSector Perform$14.00 ➝ $16.00Medium
8/9/2017HC WainwrightSet Price TargetHold$17.00High
8/9/2017Piper Jaffray CompaniesSet Price TargetSell$14.00High
8/3/2017Royal Bank of CanadaBoost Price TargetSector Perform ➝ Sector Perform$19.00 ➝ $21.00High
7/30/2017Wells Fargo & CompanyDropped CoverageSell$9.00High
7/28/2017Cantor FitzgeraldSet Price TargetBuy$23.00Low
7/27/2017BMO Capital MarketsReiterated RatingHold$15.00High
7/17/2017JPMorgan Chase & Co.Set Price TargetHold$10.00Low
7/17/2017Deutsche Bank AktiengesellschaftSet Price TargetHold$18.00 ➝ $19.00High
7/17/2017Stifel NicolausReiterated RatingBuy$35.00Low
7/14/2017Jefferies Financial GroupReiterated RatingBuy$18.00Low
7/14/2017Wells Fargo & CompanyReiterated RatingSellLow
7/14/2017Piper Jaffray CompaniesReiterated RatingUnderweight$10.00High
7/12/2017TD SecuritiesBoost Price TargetHold$15.00 ➝ $20.00Low
7/6/2017JPMorgan Chase & Co.Reiterated RatingNeutral$10.00Low
(Data available from 7/5/2017 forward)

News Sentiment Rating

0.20 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 8 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
  • 2 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 1 very positive mentions
  • 4 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
  • 5 very positive mentions
  • 9 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
  • 3 very positive mentions
  • 7 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
  • 4 very positive mentions
  • 15 positive mentions
  • 1 negative mentions
  • 3 very negative mentions

Current Sentiment

  • 4 very positive mentions
  • 15 positive mentions
  • 1 negative mentions
  • 3 very negative mentions
Bausch Health Companies logo
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Read More

Today's Range

Now: $8.53
Low: $8.03
High: $8.54

50 Day Range

MA: $10.81
Low: $7.06
High: $20.56

52 Week Range

Now: $8.53
Low: $6.88
High: $30.30


252,264 shs

Average Volume

5,811,302 shs

Market Capitalization

$3.08 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Bausch Health Companies?

The following Wall Street analysts have issued research reports on Bausch Health Companies in the last year: Bank of America Co., Barclays PLC, BMO Capital Markets, HC Wainwright, Jefferies Financial Group Inc., JPMorgan Chase & Co., Piper Sandler, Royal Bank of Canada, StockNews.com, and TheStreet.
View the latest analyst ratings for BHC.

What is the current price target for Bausch Health Companies?

0 Wall Street analysts have set twelve-month price targets for Bausch Health Companies in the last year. Their average twelve-month price target is $15.67, suggesting a possible upside of 83.7%.
View the latest price targets for BHC.

What is the current consensus analyst rating for Bausch Health Companies?

Bausch Health Companies currently has 1 hold rating and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe BHC will outperform the market and that investors should add to their positions of Bausch Health Companies.
View the latest ratings for BHC.

How do I contact Bausch Health Companies' investor relations team?

Bausch Health Companies' physical mailing address is 2150 ST. ELZEAR BLVD. WEST, LAVAL A8, H7L 4A8. The company's listed phone number is (514) 744-6792 and its investor relations email address is [email protected] The official website for Bausch Health Companies is www.bauschhealth.com. Learn More about contacing Bausch Health Companies investor relations.